Ghani Chemical Industries Limited (GCIL) began FY2027 with another strong earnings quarter, but the result has two distinct messages. Profitability improved sharply: net sales rose 35.3% year on year, gross margin expanded by 7.28 percentage points and consolidated profit after tax increased 52.1% to Rs803.0 million. Cash conversion moved the other way. Working capital absorbed almost Rs1.89 billion, leaving operating cash flow negative despite higher accounting profit.
The opening verdict is therefore positive on earnings quality at the income-statement level, but cautious on funding. GCIL widened margins while reducing its total debt since June, which strengthens the balance-sheet picture. Yet cash and bank balances almost halved and receivables increased. The next test is whether the company can preserve the higher margin while turning profit into cash rather than rebuilding working-capital pressure.
Results at a glance
- Period: three months ended September 30, 2026, compared with the quarter ended September 30, 2025. The statements are unaudited and amounts are in Pakistani rupees.
- Net sales: Rs2.49 billion, up 35.3% from Rs1.84 billion.
- Gross profit: Rs1.41 billion, up 55.2%; gross margin improved to 56.71% from 49.43%.
- Company-only operating profit: Rs1.16 billion, up 57.5%; operating margin increased to 46.53% from 39.97%.
- Finance cost: Rs163.1 million, up 18.4% from Rs137.8 million.
- Profit before tax: Rs974.9 million, up 63.3%. Company-only profit after tax: Rs783.8 million, up 48.3%.
- Consolidated profit after tax: Rs803.0 million versus Rs528.4 million; consolidated EPS was Rs1.41 versus Rs0.93.
- No interim cash dividend, bonus issue or right issue was announced.
- Company-only net cash used in operations: Rs836.9 million versus Rs254.8 million used a year earlier.
Reporting basis and reconciliation
The PSX packet contains both consolidated headline figures and detailed company-only statements. Sales, gross profit and operating lines are effectively the same because the subsidiary contribution appears below operations. Consolidated profit after tax was Rs803.0 million, while company-only profit after tax was Rs783.8 million. The roughly Rs19.2 million difference belongs to the subsidiary contribution and associated consolidation effects.
This article uses consolidated PAT and EPS for the group headline, but uses the company-only income statement, balance sheet and cash-flow statement for detailed ratios and funding analysis because those are the complete statements presented in the packet. The basis is labelled whenever the distinction matters. The company-only EPS was Rs1.37 versus Rs0.93.
What improved
Revenue growth was substantial. Net sales rose by Rs648.8 million to Rs2.49 billion. Cost of sales increased only 15.8%, far below the 35.3% rise in sales. That operating relationship drove gross profit up 55.2% to Rs1.41 billion and lifted gross margin by 728 basis points to 56.71%. The margin improvement is the quarter’s strongest feature because it was produced before subsidiary income, financing and tax.
The filing does not provide a current volume, price, product-mix, customer or utilization bridge. It is therefore not possible to say how much of the sales increase came from higher gas volumes, pricing, contract mix or other business lines. The defensible conclusion is narrower: incremental revenue carried a materially lower cost-of-sales burden than in the prior-year quarter. Any attribution beyond that would be inference.
Operating expenses increased, but not enough to offset the gross-profit gain. Distribution expense rose 24.0% to Rs6.2 million, administrative expense increased 32.8% to Rs177.6 million, and other operating expense rose 59.1% to Rs69.2 million. Even after those costs, operating profit grew 57.5% to Rs1.16 billion. Operating margin improved to 46.53% from 39.97%, showing that the stronger gross margin survived the expense line.
Income from the wholly owned subsidiary increased 20.8% to Rs106.7 million. Finance cost rose 18.4% to Rs163.1 million, but the increase was much slower than operating-profit growth. Profit before tax consequently advanced 63.3% to Rs974.9 million. Tax expense almost tripled to Rs191.1 million, so company-only PAT growth moderated to 48.3%. Consolidated PAT rose 52.1% to Rs803.0 million.
The tax movement matters when interpreting the result. The prior-year quarter carried a relatively low Rs68.6 million tax charge, while Q1 FY2027 carried Rs191.1 million. Pretax improvement was therefore stronger than the bottom-line growth rate suggests. Conversely, repeating the 63% pretax growth does not automatically imply the same PAT growth if the current effective tax burden persists.
What weakened / needs attention
The strongest concern is that higher profit did not translate into operating cash. Cash generated before working-capital changes improved to Rs1.21 billion from Rs782.3 million, broadly consistent with the stronger earnings. Working capital then absorbed Rs1.89 billion, compared with Rs161.9 million a year earlier. The cash-flow statement shows Rs1.18 billion absorbed by the trade-debt line, alongside a Rs671.3 million sales-tax outflow and smaller movements in other operating balances.
After finance cost and taxes, net cash used in operations widened to Rs836.9 million from Rs254.8 million. Capital expenditure rose 67.4% to Rs275.8 million. Investment income of Rs106.7 million partly offset that spending, leaving a Rs169.3 million investing outflow. This means the quarter’s accounting profit was not self-funding once working capital and capital investment were considered.
Financing cash flow was negative Rs463.8 million. The company received Rs800 million from its Sukuk issuance but repaid more than Rs1.11 billion of short-term borrowings, as well as long-term debt and lease liabilities. That repayment is constructive for leverage, yet it also contributed to the Rs1.47 billion decline in cash and cash equivalents during the quarter. The prior-year quarter had benefited from Rs1.41 billion of right-share proceeds, so the year-on-year financing comparison is not like-for-like.
Balance sheet: lower debt, tighter cash
Total debt fell 24.6% from June to Rs4.62 billion. Short-term debt declined 33.1% to Rs2.75 billion, while equity increased 6.7% to Rs12.44 billion. Debt was about 0.37 times equity at September, down from 0.53 times at June. Current liabilities fell 19.8% to Rs4.97 billion, faster than the 5.9% decline in current assets, improving the current ratio to 1.86 from 1.58.
Those improvements came with reduced liquidity. Cash and bank balances fell 47.1% to Rs578.8 million. Trade debts increased 8.3% to Rs3.67 billion and inventory rose 72.3% to Rs116.6 million, although inventory remains small relative to sales and receivables. The key question is whether receivables and tax balances unwind in coming quarters, allowing the profit growth to replenish cash.
The debt reduction also changes how to read finance cost. Finance expense was higher year on year because the average funding base and rates during the quarter do not necessarily match the September closing balance. If the lower closing debt is sustained, it may help later financing costs; that is a forward inference, not a benefit proven by this quarter’s reported expense.
Historical direction
The latest quarter extends a multi-year improvement visible in the official annual results. Company-only sales increased from Rs5.44 billion in FY2024 to Rs7.44 billion in FY2025 and Rs8.28 billion in FY2026. Gross margin expanded from 29.66% to 45.89% and then 53.40%. Profit after tax rose from Rs784.6 million to Rs1.99 billion and Rs2.86 billion over the same period.
Q1 FY2027’s 56.71% gross margin is above the FY2026 full-year level, while quarterly revenue is also higher than the preceding four reported quarters in the available history. That combination supports the view that the operating improvement continued into the new year. However, three annual periods are not enough to define a full industry cycle, and the current quarter’s cash deficit prevents a simple conclusion that every element of performance strengthened.
FY2026 itself combined strong earnings with strong cash generation. The official annual cash-flow statement shows Rs4.14 billion generated from operations, Rs2.13 billion used in investing and Rs1.83 billion used in financing. Q1 FY2027 is therefore a reversal in quarterly cash conversion, not evidence that the company has never generated cash. Working-capital timing will determine whether the quarter is temporary or the start of a less favorable pattern.
Business and contract context
GCIL manufactures and trades medical and industrial gases and chemicals. Its disclosed product base includes oxygen, nitrogen, argon and related gas-handling and pipeline solutions. The company has historically emphasized long-duration industrial customers: its corporate briefing described a 15-year oxygen and nitrogen supply agreement with Engro Polymer & Chemicals, an Attock Refinery liquid-nitrogen contract renewed in 2025, and supply arrangements with LOTTE Chemical Pakistan.
The February 2026 half-year report also described an exclusive agreement with Precision UK to market and install medical-gas pipeline systems in Pakistan, with healthcare projects under execution. In June 2026, GCIL separately disclosed that OGDCL awarded it the EPCC contract for processing gas from the Sono Lashari field. These initiatives broaden the opportunity set beyond commodity gas sales, but neither the Q1 filing nor the sources quantify their contribution to September-quarter revenue. They are relevant monitoring items, not proven causes of the current earnings increase.
The same distinction applies to capacity. A prior corporate briefing described expansion through additional air-separation plants, including a larger Hattar unit. Expanded capacity can support revenue growth only if utilization, customer demand and contract economics are favorable. Because the Q1 packet gives no current production, dispatch or utilization data, the article does not assign the margin change to higher plant loading.
AlphaGen model scores
The following are AlphaGen model outputs, not company-reported figures and not investment recommendations:
- Alpha QoQ Score: 76.3
- TTM Performance Score: 100
- 3Y Business Perf Score: 99.22
- Sector Leadership Score: 87.7609
The model profile is consistent with the disclosed financial direction: strong current-quarter, trailing and three-year performance, with a high relative position inside the sector. The scores do not resolve the working-capital issue and should be interpreted alongside the cash-flow statement.
What to monitor next
- Whether gross margin remains near the mid-50% range as revenue grows, and whether the company begins disclosing a volume, price and contract-mix bridge.
- Trade-debt collection and sales-tax balances. A working-capital release is needed to reconnect earnings with operating cash flow.
- Cash and bank balances after the quarter’s debt repayment, Sukuk receipt and capital spending.
- Finance cost relative to the lower September closing debt and the mix of Sukuk, short-term and long-term funding.
- Execution and disclosed revenue contribution from medical-gas pipeline projects and the OGDCL Sono Lashari EPCC contract.
- Any dividend decision. Despite strong earnings, the Q1 board announcement declared no distribution.
Evidence limitations
The official Q1 packet verifies identity, period, standalone and consolidated earnings, company-only balance-sheet movements and cash flow. It does not include management commentary, current segment results, capacity utilization, production volumes, selling prices, customer mix or a breakdown of revenue from newer contracts. The analysis therefore explains the verified financial transmission and treats earlier corporate disclosures only as dated context. It does not claim that any specific contract or expansion project caused the Q1 result.
Primary sources
PSX: GCIL financial results for the first quarter ended September 30, 2026
PSX: Ghani Chemical Industries company announcements and financials
PSX: GCIL financial results for the year ended June 30, 2026
GCIL: half-year report for the six months ended December 31, 2025
GCIL: corporate briefing on business history and long-term contracts
PSX: GCIL award of the OGDCL Sono Lashari gas-processing EPCC contract